We are live on ! Find out more
NEPH icon

Nephros

27 hedge funds and large institutions have $16M invested in Nephros in 2026 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.56% more ownership

Funds ownership: 49.9%50.45% (+0.56%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

23% less funds holding

Funds holding: 3527 (-8)

33% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 9

38% less capital invested

Capital invested by funds: $25.9M → $16M (-$9.87M)

67% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 9

Holders
27
Holders Change
-8
Holders Change %
-22.86%
% of All Funds
0.33%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
3
Increased
6
Reduced
9
Closed
9
Calls
Puts
Net Calls
Net Calls Change

NEPH Hedge Fund Activity: Q1 2026 in Review

27 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in Nephros (NEPH) for Q1 2026, worth a combined $16M — down 38% from $25.9M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of NEPH and 3 opened new positions — a net loss of 6 holders — while 9 trimmed existing stakes and 6 added.

The largest buyer was Cornerstone Capital, opening a new position worth an estimated $514K. The largest seller was Cambridge Investment Research Advisors, exiting entirely with an estimated $337K sold.

  • 27 institutional investors held Nephros (NEPH) as of Q1 2026, down from 35 in Q4 2025.
  • Funds reported $16M of Nephros stock for Q1 2026, down 38% quarter-over-quarter.
  • 3 funds opened new Nephros positions in Q1 2026 and 9 closed out, a net change of -6 holders.
  • The largest Nephros buyer in Q1 2026 was Cornerstone Capital, an estimated $514K added.
  • The largest Nephros seller in Q1 2026 was Cambridge Investment Research Advisors, an estimated $337K sold.

Based on aggregated 13F filings for Q1 2026.